NCT06762392 Effectiveness of Blood Flow Restriction in Postoperative Rehabilitation for Anterior Cruciate Ligament Injuries. A Pilot Study.
| NCT ID | NCT06762392 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Valencia |
| Condition | Anterior Cruciate Ligament Reconstruction Rehabilitation |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-01-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the effectiveness of adding Blood Flow Restriction (BFR) therapy to a standardized rehabilitation protocol in patients undergoing postoperative rehabilitation following anterior cruciate ligament (ACL) repair surgery. The main questions it aims to answer are: Does combining BFR therapy with a standardized rehabilitation protocol improve functional recovery compared to rehabilitation alone? Does the addition of BFR therapy enhance muscle strength and reduce recovery time in patients after ACL repair surgery? Participants will undergo their assigned rehabilitation protocol and will be assessed prior to and after the intervention to determine if the addition of BFR therapy to the standard rehabilitation programme significantly improves functional recovery, muscle strength, and overall rehabilitation outcomes following ACL repair surgery.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 45 years. * Patients who have undergone anterior cruciate ligament (ACL) reconstruction surgery Exclusion Criteria: * Cardiovascular comorbidities * Severe metabolic disorders or postoperative complications * Previous joint disorders requiring surgery on the affected leg * Pregnancy * Coagulation disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06762392 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anterior Cruciate Ligament Reconstruction Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06762392 currently recruiting?
Yes, NCT06762392 is actively recruiting participants. Contact the research team at f.borja.perez@uv.es for enrollment information.
Where is the NCT06762392 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06762392 clinical trial?
NCT06762392 is sponsored by University of Valencia. The trial plans to enroll 40 participants.